Tag Archives: antibody

HIV vaccines and immunotherapies “would be further along” if they had the resources of COVID-19, says leading antibody researcher

“Money does solve problems, there’s no question!” This was the answer by Professor Lynn Morris of the University of Witwatersrand in South Africa to an audience member at the 11th International AIDS Society Conference on HIV Science (IAS 2021) last week, in a plenary dealing with HIV vaccines and immunotherapy with antibodies. If HIV vaccine research, she added,… Read More »

COVID antibody drugs from Lilly and Regeneron won’t do much to boost their top lines: analysts

When Eli Lilly won emergency use authorization for its COVID-19 antibody drug, bamlanivimab, earlier this week, beating Regeneron to the finish line in a closely watched race, it was viewed as both good news and bad news. Now that Wall Street analysts have had a couple of days to digest the approval, some have concluded… Read More »

A trial is under way of the first new antibody medicine developed to treat covid-19 – MIT Technology Review

The news: Patients have started to receive the first antibody drug developed specifically to treat covid-19. It’s being tested in 32 patients at various doses in hospitals in the US. If it’s shown to be safe, the drug, referred to as LY-CoV555, will be studied in non-hospitalized coronavirus patients later this summer. The big idea:… Read More »